Model DetailsLung adenoma
Model Name |
Lung adenoma | Strain |
A/J |
Tumor Inducing Agent(s) |
Chemical/Drug : benzo[a]pyrene (BP) (BaP) (B[a]P) |
Tumor Synonyms |
lung adenoma • pulmonary adenoma • lung tumor |
Strain Synonyms |
A • A/J-Jax • Strain A • A/J, H-2a • A/Lilly • A/Jax • AJ • strain A • A/Cloudman |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Lung | Male |
observed |
~10 months |
|
Prahalad AK, Carcinogenesis 1997 Oct;18(10):1955-63 |
| Lung | Unspecified |
observed |
12 months |
|
You M, Proc Natl Acad Sci U S A 1989 May;86(9):3070-4 |
| Lung | Female |
very high |
33 weeks |
|
Wattenberg LW, Carcinogenesis 2000 Feb;21(2):179-82 |
| Lung | Female |
very high |
33 weeks |
|
Wattenberg LW, Carcinogenesis 2000 Feb;21(2):179-82 |
| Lung | Female |
very high |
33 weeks |
|
Wattenberg LW, Carcinogenesis 2000 Feb;21(2):179-82 |
| Lung | Female |
very high |
33 weeks |
|
Wattenberg LW, Carcinogenesis 2000 Feb;21(2):179-82 |
| Lung | Female |
very high |
32 weeks |
|
Estensen RD, Carcinogenesis 1993 Sep;14(9):1975-7 |
| Lung | Female |
very high |
32 weeks |
|
Estensen RD, Carcinogenesis 1993 Sep;14(9):1975-7 |
| Lung | Female |
very high |
32 weeks |
|
Estensen RD, Carcinogenesis 1993 Sep;14(9):1975-7 |
| Lung | Mixed Population |
95% (20 of 21 mice) |
~26 weeks |
|
Chen B, Carcinogenesis 1994 Sep;15(9):2031-5 |
| Lung | Unspecified |
74% (14 of 19 mice) |
30-31 weeks |
|
Carlton PS, Cancer Lett 2000 Oct 31;159(2):113-7 |
| Lung | Unspecified |
20% (1 of 5 mice) |
29-30 weeks |
|
Carlton PS, Cancer Lett 2000 Oct 31;159(2):113-7 |
| Lung | Unspecified |
60% (3 of 5 mice) |
29-30 weeks |
|
Carlton PS, Cancer Lett 2000 Oct 31;159(2):113-7 |
| Lung | Female |
0% (0 of 28 mice) |
22 weeks |
|
Kim SH, Anticancer Res 1996 Jan-Feb;16(1):465-70 |
| Lung | Female |
0% (0 of 25 mice) |
22 weeks |
|
Kim SH, Anticancer Res 1996 Jan-Feb;16(1):465-70 |
| Lung | Mixed Population |
71% (22 of 31 mice) |
9 weeks |
|
Kim SH, Anticancer Res 1996 Jan-Feb;16(1):465-70 |
| Lung | Mixed Population |
81% (25 of 31 mice) |
9 weeks |
|
Kim SH, Anticancer Res 1996 Jan-Feb;16(1):465-70 |
| Lung | Mixed Population |
93% (42 of 45 mice) |
9 weeks |
|
Kim SH, Anticancer Res 1996 Jan-Feb;16(1):465-70 |
| Lung | Mixed Population |
90% (35 of 39 mice) |
9 weeks |
|
Kim SH, Anticancer Res 1996 Jan-Feb;16(1):465-70 |
| Lung | Mixed Population |
89% (40 of 45 mice) |
9 weeks |
|
Kim SH, Anticancer Res 1996 Jan-Feb;16(1):465-70 |
| Lung | Mixed Population |
90% (26 of 29 mice) |
9 weeks |
|
Kim SH, Anticancer Res 1996 Jan-Feb;16(1):465-70 |
| Lung | Female |
0% (0 of 65 mice) |
10-21 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
18-24 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
21-27 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
24-30 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
29-35 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
35-41 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
41-47 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
45-51 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
0% (0 of 10 mice) |
15-21 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
21-27 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
24-30 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
29-35 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
35-41 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
41-47 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
0% (0 of 10 mice) |
12-21 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
21-27 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
25-31 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
45-51 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
45-51 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
43-49 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
43-49 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |